Stock IBRX IMMUNITYBIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart ImmunityBio, Inc.

Equities

IBRX

US45256X1037

Market Closed - Nasdaq
Other stock markets
 16:00:02 2024-05-31 EDT 		5-day change 1st Jan Change
6.395 USD -3.25% Intraday chart for ImmunityBio, Inc. -1.92% +27.39%
05-09 ImmunityBio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-07 ImmunityBio Shares Rise After Completion of Drug Substance Manufacturing for Cancer Treatment MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
IMMUNITYBIO, INC. Stock ImmunityBio, Inc.
 4.42B - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 118B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.28B -
ARGENX SE Stock argenx SE
 21.96B -
GENMAB A/S Stock Genmab A/S
 18.16B
  1. Stock Market
  2. Equities
  3. IBRX Stock
  4. Charts ImmunityBio, Inc.
  5. Sector Chart